FEATURED/ARCHIVES (06/05/24)
×
Heartbeat-Evoked Potential in Major Depressive Disorder: A Biomarker for Differential Treatment Prediction between Venlafaxine and rTMS? · March 2023
Articles
Neuropsychobiology
×
Outcomes of a Single-Arm Implementation Trial of Extended-Release Subcutaneous Buprenorphine Depot Injections in People with Opioid Dependence · November 2021
Articles
International Journal of Drug Policy
×
Effects of Risperidone/Paliperidone versus Placebo on Cognitive Functioning Over the First 6 Months of Treatment for Psychotic Disorder: Secondary Analysis of a Triple-Blind Randomised Clinical Trial · June 2023
Articles
Translational Psychiatry
×
Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model · November 2020
Articles
International Journal of Environmental Research and Public Health
×
Effects of Paracetamol (Acetaminophen) Ingestion on Endurance Performance: A Systematic Review and Meta-Analysis · September 2021
Articles
Sports
×
Combining Schizophrenia and Depression Polygenic Risk Scores Improves the Genetic Prediction of Lithium Response in Bipolar Disorder Patients · November 2021
Articles
Translational Psychiatry
×
Effectiveness of Internet Delivered Cognitive Behaviour Therapy Provided as Routine Care for People in the Depressed Phase of Bipolar Disorder Treated with Lithium · February 2023
Articles
PLOS Digital Health
×
Venlafaxine vs. Fluoxetine in Postmenopausal Women with Major Depressive Disorder: An 8-Week, Randomized, Single-Blind, Active-Controlled Study · May 2021
Articles
BMC Psychiatry
×
Ayahuasca: A Review of Historical, Pharmacological, and Therapeutic Aspects · October 2023
Articles
Psychiatry and Clinical Neurosciences Reports
×
Change in Negative Affective Bias Following a Single Ketamine Treatment for Treatment-Resistant Depression · August 2023
Articles
Depression and Anxiety
×
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms · July 2022
Articles
Schizophrenia Bulletin
×
Psilocybin in Neuropsychiatry: A Review of Its Pharmacology, Safety, and Efficacy · July 2022
Articles
CNS Spectrums
×
Combining CBT and Sertraline Does Not Enhance Outcomes for Anxious Youth: A Double-Blind Randomised Controlled Trial · August 2021
Articles
Psychological Medicine
×
Depression Outcomes among Patients Treated with Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial · August 2021
Articles
JAMA Neurology
×
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial · April 2021
Articles
Frontiers in Pharmacology
×
A 12-Month Audit of Clozapine Associated Myocarditis in a South Australian Local Health Network: The Importance of Screening and Personalised Titration · September 2023
Articles
Schizophrenia Research
×
Subcutaneous Ketamine Infusion in Palliative Patients for Major Depressive Disorder (SKIPMDD)-Phase II Single-Arm Open-Label Feasibility Study · November 2023
Articles
PLOS ONE
×
A Systematic Review on the Use of Clozapine in Treatment of Tardive Dyskinesia and Tardive Dystonia in Patients with Psychiatric Disorders · September 2022
Abstracts
Psychopharmacology
×
Olanzapine and Weight Loss in Early-Onset Schizophrenia · April 2023
Articles
Primary Care Companion for CNS Disorders